Measles, Mumps and Rubella Virus Vaccine Live (M-M-R Ii)
Measles, Mumps and Rubella Virus Vaccine Live is an FDA-licensed reference biologic from Merck Sharp & Dohme LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1971
Reference approved
Reference product
M-M-R Ii Measles, Mumps and Rubella Virus Vaccine Live
Merck Sharp & Dohme LLC
- Approved
- Apr 22, 1971
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Measles, Mumps and Rubella Virus Vaccine Live, in chronological order.
Reference approval
Approval date of the reference Measles, Mumps and Rubella Virus Vaccine Live product.
55 yr 11 mo ago
Frequently asked questions
Are there biosimilars approved for Measles, Mumps and Rubella Virus Vaccine Live (M-M-R Ii)?
No 351(k) biosimilars or interchangeable biosimilars referencing Measles, Mumps and Rubella Virus Vaccine Live are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.